Frontiers in Oncology | Thoracic Oncology

Original Research

Published on 23 Jan 2024

Treatment decision for recurrences in non-small cell lung cancer during or after adjuvant osimertinib: an international Delphi consensus report

in Thoracic Oncology

Myriam Mirza
Aseem Shrivastava
Cecile Matthews
Natasha Leighl
Calvin S. H. Ng
David Planchard
Sanjay Popat
Julia Rotow
Egbert F. Smit
Ross Soo

Frontiers in Oncology

doi 10.3389/fonc.2023.1330468

3,433 views

Original Research

Published on 23 Jan 2024

Pembrolizumab-combination therapy for NSCLC- effectiveness and predictive factors in real-world practice

in Thoracic Oncology

Magdalena Knetki-Wróblewska
Rafał Dziadziuszko
Tomasz Jankowski
Paweł Krawczyk
Maciej Bryl
Katarzyna Stencel
Anna Wrona
Artur Bandura
Jolanta Smok-Kalwat
Jolanta Rok-Knapińska

Frontiers in Oncology

doi 10.3389/fonc.2024.1341084

3,232 views

Case Report

Published on 23 Jan 2024

Case report: Targeted sequencing facilitates the diagnosis and management of rare multifocal pure ground-glass opacities with intrapulmonary metastasis

in Thoracic Oncology

Yingshun Yang
Guotian Pei
Mingwei Li
Xiaoxue Ma
Shuai Wang
Xianjun Min
Shushi Meng
Jiayue Qin
Huina Wang
Jun Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1276095

1,355 views

Case Report

Published on 19 Jan 2024

Case report: Acute pancreatitis in lung adenocarcinoma with small cell transformation after multiple line targeted therapy

in Thoracic Oncology

Yaoyao Jing
Xiaoxiao Li
Xiaoyuan Sun
Minghan Ren
Ruoxi Xiao
Jiayu Zhao
Zimin Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1274034

1,716 views

Case Report

Published on 18 Jan 2024

Positive response to trastuzumab deruxtecan in a patient with HER2-mutant NSCLC after multiple lines therapy, including T-DM1: a case report

in Thoracic Oncology

Junzhu Xu
Bo He
Yunan Wang
Mengjia Wu
Yanyi Lu
Zixuan Su
Shujun Liu
Fengmin Yin
Jian-Guo Zhou
Wei Hu

Frontiers in Oncology

doi 10.3389/fonc.2023.1268260

3,105 views
3 citations

Clinical Trial

Published on 18 Jan 2024

Safety and effectiveness of CIMAvax-EGF administered in community polyclinics

in Thoracic Oncology

Ramón A. Ortiz Carrodeguas
Geidy Lorenzo Monteagudo
Pedro P. Guerra Chaviano
Irene Álvarez Montané
Eva E. Salomón Saldívar
Leonardo Lobaina Lambert
Kirenia Camacho Sosa
Raúl Bermúdez Pino
Poncio Blanco Mustelier
Elba Valdés Rodríguez

Frontiers in Oncology

doi 10.3389/fonc.2023.1287902

4,744 views
6 citations

Original Research

Published on 18 Jan 2024

Prognostic and predictive role of liquid biopsy in lung cancer patients

in Thoracic Oncology

Tuncay Goksel
Su Özgür
Aslı Tetik Vardarlı
Altuğ Koç
Haydar Soydaner Karakuş
Taha Reşid Özdemir
Kadri Murat Erdoğan
Ceyda Aldağ
Ali Veral
Berna Komurcuoglu

Frontiers in Oncology

doi 10.3389/fonc.2023.1275525

2,392 views
4 citations

Systematic Review

Published on 16 Jan 2024

Efficacy and safety of neoadjuvant immunotherapy protocols and cycles for non-small cell lung cancer: a systematic review and meta-analysis

in Thoracic Oncology

Huaiyong Wang
Song Liang
Yue Yu
Yun Han

Frontiers in Oncology

doi 10.3389/fonc.2024.1276549

1,991 views
1 citation

Review

Published on 15 Jan 2024

Diagnosis, treatment, and prognosis of stage IB non-small cell lung cancer with visceral pleural invasion

in Thoracic Oncology

Zegang Ruan
Xin Zhuo
Chenyang Xu

Frontiers in Oncology

doi 10.3389/fonc.2023.1310471

4,556 views
7 citations

Case Report

Published on 12 Jan 2024

Primary mediastinal Ewing’s sarcoma presenting with sudden and severe chest pain: a case report

in Thoracic Oncology

Chen Su
Xiaobo Zhu
Junjie Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1290603

1,414 views

Original Research

Published on 11 Jan 2024

Cost-effectiveness analysis of serplulimab combination therapy versus chemotherapy alone for patients with extensive-stage small cell lung cancer

in Thoracic Oncology

Zhiwei Zheng
Hongcai Chen
Hongfu Cai

Frontiers in Oncology

doi 10.3389/fonc.2023.1259574

2,030 views
6 citations

Systematic Review

Published on 11 Jan 2024

Non-small cell lung cancer with MET amplification: review of epidemiology, associated disease characteristics, testing procedures, burden, and treatments

in Thoracic Oncology

Mo Yang
Erin Mandal
Frank X. Liu
Richard M. O’Hara
Beth Lesher
Rachel E. Sanborn

Frontiers in Oncology

doi 10.3389/fonc.2023.1241402

7,560 views
6 citations

Original Research

Published on 10 Jan 2024

Cerebrospinal fluid ctDNA testing shows an advantage over plasma ctDNA testing in advanced non-small cell lung cancer patients with brain metastases

in Thoracic Oncology

Xiaocui Liu
Fengjun Mei
Mei Fang
Yaqiong Jia
Yazhu Zhou
Chenxi Li
Panpan Tian
Chufan Lu
Guangrui Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1322635

2,239 views
4 citations

Perspective

Published on 10 Jan 2024

Perspective: rethinking therapeutic strategies in oncology

in Thoracic Oncology

Edward F. Patz
Elizabeth B. Gottlin
George R. Simon

Frontiers in Oncology

doi 10.3389/fonc.2023.1335987

1,294 views

Original Research

Published on 09 Jan 2024

ALK F1174S mutation impairs ALK kinase activity in EML4-ALK variant 1 and sensitizes EML4-ALK variant 3 to crizotinib

in Thoracic Oncology

Jikui Guan
Tzu-Po Chuang
Anders Vikström
Ruth H. Palmer
Bengt Hallberg

Frontiers in Oncology

doi 10.3389/fonc.2023.1281510

2,176 views

Opinion

Published on 09 Jan 2024

The great need to overcome osimertinib resistance in advanced non-small cell lung cancer: from combination strategies to fourth-generation tyrosine kinase inhibitors

in Thoracic Oncology

Giuseppe Bronte
Alessia Belloni
Luana Calabrò
Lucio Crinò

Frontiers in Oncology

doi 10.3389/fonc.2023.1308460

3,846 views
3 citations